🚨NEW PAPER🚨 Huge congrats to @KamKaplanRFUMS on his first first-author data paper and @Lainey10yes on her first ever publication!! Seriously so proud of this lab always. Summary below (2-4).

Happening today!

. @ACNPorg panel not selected 😭😭 but I would still love to attend! Anyone have a guest slot available for a past travel awardee who is applying for membership this year? 🙏

📣 Today is a turning point in what we know about brain health. The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S. The findings,

If you’re at #AAIC25, come stop 🛑 by and say 👋🏻. Let’s chat about neuropsychiatric symptoms in aging, AD, and menopause. #159 exhibit hall.

I’m really glad conferences started offering races ☺️! Technically my first race in a different country. Bucket list item ✅ #AAIC25

Excited to see this work out! Combination therapy could be the future of AD treatments. Loved being a part of this study during my time in the Denny lab bridging the ketamine and AD crews. @BriKChen @DrChristineAnnD #ENDALZ https://t.co/Lhj4nq3KNP

We need to talk about the effects of US science funding cuts on the lives of scientists and on the future of discovery & innovation in this country. I am proud to be joining a panel led by @BioRender ft. speakers from across disciplines, career stages, and roles in science (1/3)

My favorite is the Summer lab explosion. I’m always impressed with the passion and new ideas from our summer interns and volunteers!! Thanks Tala Coffee Roasters for an awesome lab meeting space ☕️. Not pictured: My orange juice coffee combo 🤯.

We are now examining the role of interneurons in this circuit (SST!) and how repeated use impacts aged and AD mice.

Here, we examine the acute effects of Xanax on fear memory and activated neuronal ensembles. With a single injection, we found memory impairment in both males and females and alterations in hippocampal encoding and retrieval cell activation, specifically in females.

The aged population is heavily prescribed benzodiazepines (BZDs) for treatment of anxiety, but BZD use can result in memory impairments. While BZDs can be beneficial, long-term use might not be helpful in a population at risk for memory decline and Alzheimer's disease (AD).

Reminder: if you’re a scientist whose funding has been cut or impacted, I would love to interview you for a podcast I’m working on, to amplify your work. Reach out by DM or email! Hoping to release our first two episodes next week. Thanks to @estef_azevedo for artwork!

Each of us is a complicated web of emotions! @pixarinsideout @Lainey10yes @KamKaplanRFUMS @SashaFeshchenko #memoryengram #corememory #HappyHalloween

First @SfNtweets for the Hunsberger Lab! Go say hi and talk science with this awesome crew 👇🏻 #proudPI #RFU @Lainey10yes @KamKaplanRFUMS

Disease-modifying anti-amyloid beta treatments are becoming an essential part of neurologists’ repertoire for treating Alzheimer’s disease. Our commentary highlights the critical factors that will influence the clinical impacts of this treatment class! https://t.co/fqqZQkuU7X

Excited to finally share this labor of love! This was a huge team effort. Thanks to everyone involved, Christine for believing in it, the @NIHAging for funding, Dr. Seonjoo Lee for making my translational dream come true, and all the students who helped analyze brain images 🙏

📣We are hiring!!! Postdoc and technician positions available! See our website for details: https://t.co/nMEfohHsJ9 Please RT! @PostdocJobs

“The Real Cotsx” 😂 very entertaining lab meeting today. #newmascot

🥹